tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Viking Therapeutics (VKTX)
NASDAQ:VKTX
US Market
VKTX
Viking Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Viking Therapeutics (VKTX) Stock News & Sentiment

Compare
5,873 Followers
Viking Therapeutics’ Promising VK2735 Trials and Strategic Advancements Drive Buy Rating
Premium
Ratings
Viking Therapeutics’ Promising VK2735 Trials and Strategic Advancements Drive Buy Rating
9d ago
VKTX
Viking Therapeutics’ Strategic Advancements and Promising VK2735 Trial Support Buy Rating
Premium
Ratings
Viking Therapeutics’ Strategic Advancements and Promising VK2735 Trial Support Buy Rating
9d ago
VKTX
Positive Outlook for Viking Therapeutics: Strong Trial Enrollment and Upcoming Milestones Suggest Upside Potential
Premium
Ratings
Positive Outlook for Viking Therapeutics: Strong Trial Enrollment and Upcoming Milestones Suggest Upside Potential
9d ago
VKTX
Viking Therapeutics Secures Manufacturing Agreement with CordenPharma, Boosting Growth Prospects and Investor Appeal
Premium
Ratings
Viking Therapeutics Secures Manufacturing Agreement with CordenPharma, Boosting Growth Prospects and Investor Appeal
24d ago
VKTX
Viking Therapeutics Secures Strategic Manufacturing Agreement, Boosting Investor Confidence and Phase 3 Trial Prospects
Premium
Ratings
Viking Therapeutics Secures Strategic Manufacturing Agreement, Boosting Investor Confidence and Phase 3 Trial Prospects
24d ago
VKTX
Viking Therapeutics Secures Strategic Manufacturing Agreement with CordenPharma, Boosting Growth Potential and Earning Buy Rating
Premium
Ratings
Viking Therapeutics Secures Strategic Manufacturing Agreement with CordenPharma, Boosting Growth Potential and Earning Buy Rating
24d ago
VKTX
Strategic Manufacturing Deal Boosts Viking Therapeutics’ Stock Outlook
Premium
Ratings
Strategic Manufacturing Deal Boosts Viking Therapeutics’ Stock Outlook
24d ago
VKTX
More VKTX News >

VKTX News on the Web

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade
Zacks
Neutral
Which Healthcare Stock Is the Best Buy Right Now?
MarketBeat
Neutral
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
Zacks
Neutral
VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug
Zacks
Neutral
Viking Therapeutics Completes Enrollment for Phase 2 Trial of VK2735 in Obesity Treatment
GuruFocus News
Neutral
Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know
Zacks
Neutral
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
CNBC
Neutral
MarketBeat Week in Review – 03/17 - 03/21
MarketBeat
Neutral

News Score - Last 7 Days

Neutral
VKTX
Sector Average
Media Buzz
This Week2 articles
Weekly Average7.25 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VKTX’s Media Buzz Sentiment?
2 articles about VKTX were published this week. In an average week, 7.25 articles are published.
    What is VKTX’s weekly average amount of articles?
    In an average week, 7.25 articles about VKTX are published.
      What is VKTX’s News Sentiment?
      50% of articles about VKTX were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        GRIGRI Bio
        SLPSimulations Plus
        CORTCorcept Therapeutics
        LFCRLifecore Biomedical
        HAWPFHaw Par
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing